Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2021-05-28 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the header 'DGAP-DD: Fresenius SE & Co. KGaA english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This content directly matches the definition for Director's Dealing reports, which corresponds to the filing code DIRS. The document details the transaction (Disposal), the person involved (Dr. Francesco De Meo, Member of the managing body), and the specific trade details (price and volume).
2021-05-28 English
SdK Anleger Forum
Investor Presentation Classification · 98% confidence The document is titled 'SdK Anleger Forum' (SdK Investor Forum) and is dated May 11, 2021. It contains slides covering investment highlights, global trends, detailed segment performance (Fresenius Medical Care, Kabi, Helios, Vamed), dividend policy, shareholder structure, historical stock performance, and a financial calendar. The content is clearly designed for presentation to investors, focusing on strategy, performance review, and outlook, which strongly aligns with the definition of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement (RPA/RNS). The presence of a financial calendar listing the 'Hauptversammlung' (AGM) date suggests it might be used in conjunction with AGM materials, but the core content is an investor presentation.
2021-05-11 English
Q1 statement / Q1 financial report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for Fresenius Group for Q1 2021. It contains detailed financial statements, management discussion and analysis (MDA), segment reporting, and balance sheet data. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-10 German
Conference Call Q1 Results 2021, Fresenius
Call Transcript Classification · 98% confidence The document text explicitly states "Conference Call | Q1/21 Results" at the beginning and contains an "Agenda" followed by detailed operational and financial updates for Q1/21 across various business segments (Fresenius Kabi, Helios, Vamed). It includes key performance indicators, P&L statements, cash flow figures, and forward-looking guidance, which are typical components of an earnings call presentation. The structure and content strongly indicate this is the material used for a conference call discussing quarterly earnings, matching the definition for Call Transcript (CT), even though this is the presentation material rather than the full transcript itself. Given the options, CT is the most appropriate classification for earnings call materials.
2021-05-06 English
Investor Relations Company Presentation
Investor Presentation Classification · 98% confidence The document is titled "Company Presentation" dated May 2021. It contains an agenda, investment highlights, strategic roadmaps, ESG updates, detailed segment performance (Fresenius Medical Care, Kabi, Helios, Vamed), Q1/21 Profit and Loss statements, Cash Flow data, and a full FY/21 Financial Outlook. This structure, combining high-level strategy with detailed quarterly financial results and forward guidance, is characteristic of an Investor Presentation (IP) or a presentation accompanying an earnings release. Since it is a comprehensive presentation deck covering strategy, segment deep dives, and financial metrics for a specific period (Q1/21), 'Investor Presentation' (IP) is the most appropriate classification, rather than just an 'Earnings Release' (ER) which is typically just the press release highlights.
2021-05-03 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly mentions the 'Publication of total number of voting rights' as of April 30, 2021. It details a 'Type of capital measure' related to a 'Conditional capital increase' under German Securities Trading Act (WpHG) Section 41. This content directly relates to changes in the total number of shares/voting rights, which aligns with announcements concerning capital structure changes or voting rights updates. While it is a regulatory announcement (DGAP/EQS), the specific subject matter—the total number of voting rights—is a distinct event. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for a formal announcement detailing the total voting rights following a capital measure, as opposed to 'DVA' (Declaration of Voting Results) or 'CAP' (General Financing Update). Given the specific focus on the total voting rights count, SHA is selected.
2021-04-30 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.